At the request of AHA and others, the Drug Enforcement Administration has taken steps that will address the IV opioid shortages. DEA recently granted some additional quota for raw materials to West-Ward Pharmaceuticals and Fresenius Kabi USA so that they can produce certain injectable opioid medications that are experiencing severe shortages. The Food and Drug Administration has updated its drug shortage database to reflect the upcoming availability of these products. Both drug companies will continue work with DEA on additional quota requests to try to accommodate hospitals’ supply needs for these products in the upcoming months. On Feb. 27, the AHA and several other national pharmacy, medical, and safety organizations sent DEA a letter urging the agency to temporarily adjust the aggregate production quotas for injectable opioid medications in short supply to allow other manufacturers to supply product until the shortages resolve. For more information about how to access these products, the FDA’s database includes customer service contact information for these and other drug companies. The AHA this week shared with hospitals and health systems a new resource developed by the American Society of Health-System Pharmacists and the University of Utah Drug Information Service with suggestions for managing the injectable opioid shortages.

Related News Articles

Headline
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug…
Headline
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014…
Headline
Commenting today on the Medicare Payment Advisory Commission’s draft recommendations for 2020, AHA said it supports the recommendation to provide current law…
Headline
Hospitals and health systems may apply through Feb. 19 for the 2019 AHA Equity of Care Award, which recognizes organizations participating in the AHA's #…
Headline
Derrick Jones, CEO of Lovelace Rehabilitation Hospital in Albuquerque, N.M., will serve as 2019 chair of the AHA's Section for Long-Term Care and…
Headline
The AHA's Center for Health Innovation Jan. 16 at 1 p.m. ET will host a webinar for hospital and health system leaders to make sense of the various types of…